Clozapine Orally Disintegrating Tablets, 25 mg and 100 mg is the generic version of Jazz Pharmaceutical's FazaClo
, whose active ingredient is Clozapine, generated about $34 million in U.
Since completing the acquisition of Alamo, the company has recorded as net deferred revenues wholesaler shipments for FazaClo totaling $4.
FazaClo is also indicated for reducing the risk of suicidal behavior in patients with schizophrenic or schizoaffective disorder.
Completed the previously announced sale of FazaClo to Azur Pharma Inc.
Total net revenues from continuing operations for fiscal 2007 (excluding FazaClo net revenues) were $9.
We're confident that psychiatrists and their patients will welcome the new freedom that FazaClo
tablets present," says Neal Cutler, founder, president and chief executive officer of the California-based company.
We have gained additional clarity on the regulatory path forward for our core CNS asset Zenvia[TM], secured non-dilutive operating capital by divesting FazaClo, a non-core asset, and taken significant steps to lower our net cash burn rate.
The Company believes that the net proceeds from the sale of FazaClo, plus the cash, cash equivalents and unrestricted investments in securities at June 30, 2007 will be sufficient to finance operating expenses through the end of the next fiscal year, including the planned initiation of the confirmatory Phase III clinical trial of Zenvia in patients with PBA/IEED.
The Company believes that the net payments from the sale of FazaClo
, plus the cash, cash equivalents and unrestricted investments in securities at June 30, 2007 will be sufficient to finance operating expenses through the end of the next fiscal year, including the initiation of the planned confirmatory Phase III clinical trial of Zenvia[TM] in patients with involuntary emotional expression disorder (IEED), otherwise known as pseudobulbar affect (PBA).
is indicated for the management of severely ill schizophrenic patients who fail to respond adequately to standard drug treatments for schizophrenia.
was only available in 25 mg and 100 mg dosage strengths in special blister packaging.
Reported that the Company is in discussions with several parties that have expressed interest in potentially acquiring certain Company assets, including FazaClo
and several investigational compounds.
net wholesaler shipments for the quarter ended March 31, 2007 were approximately $4.
Announced receipt of an approvable letter from the FDA for a new formulation of its currently marketed antipsychotic drug FazaClo